Are Major aortopulmonary collateral arteries (MAPCAs) hereditary?

Major aortopulmonary collateral arteries (MAPCAs) are abnormal blood vessels that develop in individuals with certain congenital heart defects, such as pulmonary atresia or tetralogy of Fallot. These collateral arteries serve as alternative pathways for blood flow to the lungs when the normal pulmonary arteries are either absent or too small.

The development of MAPCAs is not directly linked to hereditary factors. Instead, it is believed to be a result of abnormal embryonic development during the formation of the heart and blood vessels. The exact cause of this abnormal development is not fully understood, but it is thought to involve a combination of genetic and environmental factors.

While there may be a genetic predisposition for certain congenital heart defects, including those associated with MAPCAs, the development of these collateral arteries themselves is not considered hereditary. However, if a parent has a congenital heart defect, there may be a slightly increased risk of their child also having a heart defect, including the presence of MAPCAs.

It is important to note that the presence of MAPCAs can vary in severity and may require medical intervention. Treatment options may include surgical procedures to redirect blood flow or repair the underlying heart defect. The management of MAPCAs typically involves a multidisciplinary approach, with input from cardiologists, cardiac surgeons, and other healthcare professionals.